Spun off from nonprofit FutureHouse after major pharma interest, Edison Scientific secured significant venture funding to commercialize AI agents for drug development.
HP has partnered with OpenAI to embed cutting-edge agentic AI into its customer services, workforce platforms, and software development, aiming to enhance efficiency and automate workflows.
The US dollar has risen significantly this year, propelled by expectations of Federal Reserve rate hikes and growing investor enthusiasm for AI-related US assets.
Auto loan refinancing volumes nearly doubled in early 2026 as falling interest rates and rising vehicle costs prompt consumers to seek better loan terms.
Major tech firms blame surging chip and memory costs driven by AI demand for recent price hikes in devices and gaming consoles that are years old.
Insilico Medicine teams with SK Biopharmaceuticals to harness AI in discovering and developing drugs targeting neuroimmune disorders of the central nervous system, in a deal worth up to $2.5 billion.
Google has limited Meta’s ability to use its Gemini AI models due to capacity shortfalls, slowing Meta’s AI projects and prompting efficiency measures among its teams.
Countries accelerate investments in domestic uranium enrichment to secure high-assay low-enriched uranium (HALEU) crucial for next-generation nuclear reactors amid supply challenges.
The National Nuclear Security Administration revealed an 11-foot AI-developed flight test vehicle designed to accelerate nuclear deterrent research during a public exhibit.
Italy’s competition authority investigates Microsoft over unclear communication and price hikes linked to new AI features in Microsoft 365 subscriptions.